Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
163.78 Up 1.04(0.64%) 3:59PM EDT
|After Hours : 164.00 Up 0.22 (0.13%) 7:29PM EDT
Prev Close:162.74
Open:164.12
Bid:157.00 x 100
Ask:165.20 x 100
1y Target Est:196.95
Beta:0.51
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:161.70 - 165.02
52wk Range:100.89 - 185.43
Volume:1,172,845
Avg Vol (3m):1,209,330
Market Cap:32.40B
P/E (ttm):99.02
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 0.64%32.40B
AMGNUp 0.54%93.35B
BAXDown 0.17%41.42B

Key Statistics

Forward P/E (1 yr):28.34
P/S (ttm):16.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.00
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback